Search results
Results from the WOW.Com Content Network
By 1926–27, the PDSA was operating 57 clinics and three travelling caravans, and had treated almost 410,000 patients in a year at a cost of £43,085 at its various premises across Britain. [ 1 ] In 1931, an annual Christmas Market of the People's Dispensary for Sick Animals was being held at the Royal Albert Hall on 24-25 November.
The World Health Organization and Health Action International (WHO/HAI) made a conjoint effort to systematize the methodology of medicine price surveys and ERP usage, first publishing the WHO/HAI methodology in manual in 2003, [3]: 195 which is frequently used in price studies in unregulated prices context often found in low and moderate income ...
The prices in the private sector are often many times (and can be up to 80 times) the international reference price. This makes treatment unaffordable. [6]: 4 The prices in the guide are given in US dollars converted using the exchange rate at the time. Exchange rate fluctuations may cause the wide variations in cost over time. [7]
Medication costs can be the selling price from the manufacturer, that price together with shipping, the wholesale price, the retail price, and the dispensed price. [3]The dispensed price or prescription cost is defined as a cost which the patient has to pay to get medicines or treatments which are written as directions on prescription by a prescribers. [4]
In the U.S., the Emergency Medical Treatment and Active Labor Act requires that hospitals treat all patients in need of emergency medical care without considering patients' ability to pay for service. [27] This government mandated care places a cost burden on medical providers, as critically ill patients lacking financial resources must be treated.
Maria Elisabeth Dickin CBE (nickname Mia; 22 September 1870 – 1 March 1951) was a social reformer [1] and an animal welfare pioneer who founded the People's Dispensary for Sick Animals (PDSA) in 1917. The Dickin Medal is named for her.
Cost-minimization is a tool used in pharmacoeconomics to compare the cost per course of treatment when alternative therapies have demonstrably equivalent clinical effectiveness. [ 1 ] Therapeutic equivalence (including adverse reactions, complications and duration of therapy) must be referenced by the author conducting the study and should have ...
Throughout the past decade, there have been activist movements that have influenced the procurement lower HIV drug prices at greater accessibility. In 2000, the cost for first-line treatment was over $10,000 per patient per year, [1] and nearly two decades later in 2018, the cost has decreased to as low as $75 per patient per year. [5]